Electra Therapeutics, Inc. (ETRA)

Electra Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Electra Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	-	11.5	7.05
Research & Development	-	50.39	19.27
Operating Expenses	-	61.89	26.32
Operating Income	-86.75	-61.89	-26.32
Interest Expense (Income)	-1.24	0.07	-1.52
Other Expense (Income)	0.02	0.02	-0.01
Pretax Income	-95.2	-61.98	-24.79
Net Income	-85.53	-61.98	-24.79

Additional Metrics

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-75.32	-61.22	-26
Free Cash Flow Growth	-	-	-
EBITDA	-77.7	-62.09	-27.03
Depreciation & Amortization	-0.61	-0.19	-0.72
EBIT	-77.09	-61.9	-26.31